<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 139 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page138.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=139">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 139 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 139</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=139"><img src="../thumb/139.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>108 / 2020-04                                                        Cardio-Vascular Agents - 7.3.8
   Drug interactions: Li eliminat.reduc., other antihypertens./ diu-  Non-diabet.& diabet.nephropathy: Init. 1,25 mg dly. Accord.to   24 hrs. aft.ac.MI in haemodynamic.stable pts.to prev. subseq.L ven-
   ret. incr.eff., ß-adrenerg.agents /methyldopa/Ca entry block. po-  respons.doubl.dos.at 2-3 wk. interv. Max.10 mg dly.  tric.dysfunct./HF to improve surviv. tog.with std.treatm.such as aspir./
   tent.hypotens.eff.           Diuret.pre-treat.pts: Discont.diuret.2-3 days bef. init ther. Where di-  thrombolyt./β-blocks. where appropr.
   ENAP-CO, Pharma Dynamics     uret.cannot.be discont.init.with. 1,25 mg adjust.accord.to BP respons.  (S3) TABS, 43/7.1.3/0663, 0664, 0665
                                                              3000546-001: 5 mg, 30, R27,60
                                MI/stroke/CV death risk reduct.: Init: 2,5 mg once dly. Incr.grad.
   Enalapril mal. 20 mg, hydrochlorothiaz. 12,5 mg.  depend.on tol.in which case dos. should be doubl.aft.one wk.& doubl.  3000547-001: 10 mg, 30, R27,60
   Indications: Hypertens.when pts.stabilis.on these indiv.compon.  again aft.3 wks. to usual maint.dos.of 10 mg once dly.  3000548-001: 20 mg, 30, R27,60
   in same dosag.               Contraindications: Angio-oed.hist.relat.to prev. ACE inhibit.ther./  Dosage: Admin.as sngl.dly dos.pref.at the same time every day.
   (S3) TABS, 34/7.1.3/0088     angiotens.recept.block., heredit./ idiopathic angioed., aort.stenos.,   Mild to mod. hypertens: Init.10 mg recomm. Dos. should be adjust.
   891287-008: 30, R92,40       hypertrop. obstruct. cardiomyopathy, sev imp.ren funct., ren. artery   accord.to BP respons. Usual effect.maint.dos.is 20 mg/day as sngl.
   Dosage: 1 tab dly. May be incr.to max.2 tabs.dly.if necess.  stenos.in pts.with sngl.kidn., concom.K  spar. diuret.ther./Li-, porphyr.,
                                                +
   Contraindications: Anur., angioneurot.oed. hist.relat.to prev.ACE   pregn., not recomm. in childr.  dos. Max. 40 mg/day. Dos.may be furth.incr.if desir. therapeut. eff.
                                                              not achiev.in 2-4 wks.on cert.dos. lev.
   inhibit.ther., sulphonamide sens., pregn.& lactat., concom.Li., safety   Side effects: Freq: Dizzin., headache, fatig., dry cough., naus., diarrh.
   & effic.in childr.not est., ren.insuff.  Less freq: Decr.WBC count/ haemoglob./ haematocr., bone marr.de-  Diuret.-treat.pts: Discont.diuret.2-3 days bef.init. lisinopril ther.
                                                              Init.ther.with 5 mg dos. in hypertens.pts. in whom diuret.cannot be
   Side effects: Dizzin., fatig., musc.cramps/spasm, GI disturbs., aes-  press., anaem., thrombocytopen., agranulocytos., haemolyt. anaem.,
   then., orthostat.effs.incl. hypotens., headache, cough, impot., CNS/  hypersens./angioed., intest. angioed., hyperkalaem., hyponatraem.,   discont. Subseq. lisinopril dos.adjust.accord.to BP respons. Diuret.
                                                              may be resum.if reqd.
   psych. effs., vertigo, paraesthes., CV effs., dyspn., angio-neurot.oed.,   incr.bld. urea/ ser.creatin., mood alterat., mental confus., paraesthes.,
   ren.dysfunct./fail., decr.libido, dry mouth, gout, tinnit., arthralg., fev.,   vertigo, sleep disturbs., MI, palpitat., tachycard., chest pain. orthostat.  Renovasc.hypertens: Low.dos.to 2,5 or 5 mg.
                                                              Congest.heart fail: Init.2,5 mg once dly.in pts. not adeq.contr.by
   serositis, vasculit., myalg., arthrit., photosens., skin reacts. incl. Stev.  effs.incl. hypotens. /cerebrovasc.accid., bronchosp., rhinit., sinusit.,
   John. syndr./tox.epiderm.necrolys./ erythema multiforme/exfoll.  digital.&/diurets. Dos.adjustm bas. on clinic.respons. Incr.by increm.
   dermatit., hyperglycaem., hypo-/hyperkalaem., hyponatraem., bld.  abdom.pain, indigest., dry mouth, pancreatit., vomit., taste disturbs.,   of no great. than 10 mg, at interv.of no less than 2 wks & to high.dos.
                                hepatit. (hepatocell./ cholestat.), jaund, incr.ser.bilirub./liv. enzym.,
   dyscras., hepatocellul./cholestat.jaund., pancreatit., sialoadenit.,   toler.up to max.of 35 mg once dly. Pts.at high risk of symptom.hypo-
   xanthops., resp.distress, interstit. nephrit., anaphylax., glycosur.,   rash, urticar., diaphores., alopec., prurit., psorias., sev.skin disords.,   tens.to have condits. check. bef.init.ther. Monit.eff.of start.dos. on BP.
                                asthen., uraem., oligur., anur., ren.dysfunct., ac.ren.fail., impot., fev.,
   electrol. imbal., blurr.vis., hepatit., ileus, bronchosp., asthma, sore   Ac.MI: 5 mg within 24 hrs.of sympt.onset.follow. by 5 mg aft.24 hrs.
   throat, hoarsen., card.rhythm disturbs., ang.pect., CV effs.incl.MI/  vasculit., myalg., arthrit./arthralg., posit.ANA, elev. ESR, eosinophil.,   then 10 mg aft.48 hrs.& then 10 mg dly.thereaft.x6 wks. In case of
                                leucocytos., rash, photosens.
   CVA, rhinorrh., alopec, flush., stomatit., glossit., oligur., pulm. infil-  low syst.BP (&lt;120mmHg) an init.dos.of 2,5 mg should be used dur.
   trat., hepat.fail., pemphig., dry persist.cough, SLE activ./exacerbat.,   Warnings and special precautions: Cerebrovasc./ ischaem.heart   first 3 days aft.infarct. If hypotens.occurs (syst. BP &lt;100 mmHg)ad-
                                dis., salt/vol.deplet. pts., pts. at high risk of symptomat.hypotens.,
   sens.reacts.with/without allerg.hist./ bronch.asthma, gluc.tol.imp.,   min.5 mg dly.as maint. dos. with tempor.reduct.of 2,5 mg if need.
   incr. cholester./ triglycer.lev., poss.hyperuricaem.&/ gout precipitat.  sev. autoimmune dis./immunosuppressive ther., ac.MI with evid.  Withdr. treatm. if prolong.hypotens.(syst.BP &lt;90mmHg for more than
                                of ren.fail./at risk of hypotens., bone marrow. depress., diab.mel-
   Special precautions: Discont.& change if pregn.occurs/contempl.,   1 hr) occurs. Pts.develop.HF sympt. should contin.ther.
   pass.through placenta, appears in breast milk, ren.impairm., poss.  lit., hyperkalaem., imp. ren.funct./renovacul.dis./ren.artery stenos.,   Contraindications: Concom.aliskiren-contain. meds., angioed.
                                not recomm.in dialys.pts., anaplylact. reacts.with desensitis.proto-
   life-threat. anaphylact.reacts.dur.hymenoptera desensitis.treatm./  hist.relat.to prev. ACE inhibit./ angiotens.recept.block.in which case
   haemodialys.with high-flux membr., imp.hepat.funct./progress.liv.  cols/high flux membr.dialys./low dens.lipoprot.apheres.with dextr.   no re-challenge aft. angioed.react., heredit./ idiopath. angioed., hy-
                                sulph., incr.incid.of angioed.in black pts., surg. & anaesth., imp.liv.
   dis., discont. & init.appropr.ther.in case of angioed.of face/ extre-  pertroph.obstruct.cardiomyopathy, sev. ren.funct. impairm., bil.ren.
   mit./lips/tong.glott. &/larynx, angio-oed.hist. unrelat.to ACE-inhibit.  funct., crosses placenta, teratogenic.in anim., safety in lactat.not est.  artery stenos., ren. artery stenos.in pts.with sngl.kidn., aort.stenos.,
                                Interactions: K -supplem./-spar.diuret.incr. hyperkalaem. risk, diu-
                                       +
                                                                  +
   at great risk, monit.fluid & electrol., antidiab.agents dos.adjustm.,   concom. K -spar.diuret., porphyr., Li-ther., pregn.& lactat., safety &
   bilat./sngl. ren.artery stenos., surg./anaesth., poss.underly. hyper-  ret/alcoh..& antihypertens. potent. respons., antihypertens.eff.decr.  effic. in childr.not est.
   parathyroid.in case of mark.hypercalcaem., concom.ganglion./adr-  by NSAIDs, Li-conc.incr.  Side effects: Freq: Dizzin., headache, cough, diarrh., vomit. Less
   energ.block.agents., ischaem. heart/cerebrovasc.dis.as excess.fall   LISINOPRIL CO UNICORN, Unicorn  freq: Bld.dyscras., autoimmune dis., hypersens./angioed.reacts.some
   in BP could result in MI/CVA.  Lisinopril 10(20)mg, hydrochlorothiazide 12,5(12,5) mg.  being fatal, SIADH, CNS effs., hyperkalaem./ hyponatraem., hypo-
   Drug interactions: Thiaz.ther.may imp.gluc.tol., alcoh., barbits.&   Indications: Mild to mod.hypertens. stabilis.on indiv.component.  glycaem., psych.disords., vertigo, orthostat.effs.incl. MI/CVA, hypo-
   narcot.may potent.orthostat. hypotens., corticoster.& ACTH intens.  giv.in same proport.  tens., Raynaud’s phenom., bronchosp., rhinit., sinusit., allerg. alveolit.,
   electrol. deplet., NSAIDs may reduc.diuret./natriuret.& antihyper-  (S3) TABS, 37/7.1.3/0477, 0478  eosinophil.pneumon., GI/taste/ olfact. disturbs., pancreatit., hepatit.,
   tens.eff., poss.decr.pressor amin. respons., reduc.Li ren.clear., incr.  716943-001: 10/12,5 mg, 30, R55,80  jaund., incr. liv. enzym., hepat.fail., skin reacts.incl.cutan. pseudolym-
   tubocurarine responsiven., K  losing eff.of thiaz.diuret.attenuat. by   716945-001: 20/12,5 mg, 30, R92,70  phoma, sev.skin disords.incl.pemphig./ tox. epiderm. necrolys./Stev.
               +
                 +
            +
   enalapril eff., incr.ser.K  lev.with K -spar. agents/ K cont.salt substit/   Dosage: 1 tab once dly. taken at approx. same time each day. Max   Johns.syndr./ erythema multiforme, diaphores., alopec., sweat., urin./
                       +
   K supplem., thiaz.may decr.urin.Ca excret.  2 tabs once dly.if respons. inadeq.aft.2-4 wks.  ren.disords.incl.ac.ren.fail., impot., gynaecomast., fatig., asthen.,
   +
   HR-ENALAPRIL MALEATE 5; 10 & 20, Sandoz [P/S]  Contra-indications: Anur., hist.of angioed. with ACE-inhibit., he-  sympt.compl. incl.fev./vasculit./ myalg./ arthrit./arthralg./ANA., elev.
                                                              erythrocyte sediment.rate/ eosiniphil./ leucocytos.
   Enalapril maleate            redit./idiopath angioed., sulphonam. sens., pregn. & lactat., aortic.  Warnings and special precautions: Treatm.to be stopp.& chang.
   Indications: Hypertens., CHF usual.in comb.with diuret. & digital.,   stenos./ hypertroph.cardiomyopathy, concom.Li ther., safety & ef-  to altern.antihypertens.with est. safety profile if pregn.plann./occurs,
   asymptomat.L ventric.dysfunct.  fic.in childr.not est.     pass.through placenta, dual block.of RAAS with concom.ARB’s/ ACE
   (S3) TABS, 33/7.1.3/0506, 0507, 0508  Side-effects: GI disturbs., headache, dry mouth, dizzin., fatig.,   inhib./aliskiren poss.incr. hypotens./ hyperkalaem. risk & decr.ren.
   867845-007: 5 mg, 30, R41,34  asthen., paraesthes., vertigo, fev., hypoaesthes., CNS/psych.effs.,   funct., hypersens./ angioed. with ser.sympt.which may occur at any
   867853-018: 10 mg, 30, R58,02  musc.cramp/ spasm, weakn., hyperglycaem., glycosur., jaund., pan-
   867861-002: 20 mg, 30, R98,30  creatit., hyperuricaem., hepatit., persist. dry cough., resp.distress.  time dur.ther., high.angioed.rate in black pts., not for use in renovasc.
                                                              dis., sev.resist.hypertens., elderly/ periph.vasc.dis./gener.atheroscle-
   Dosage: Essent.hypertens: Init.10-20 mg dly. Maint: 20 mg dly.  incl.pneumonit. & pulm. oed., hypersens./anaphylact.reacts., bron-
   Renovasc.hypertens: Init. 5 mg or less. Most pts.respond.to   chosp., rhinit., sinusit., pulm.infiltrat., palpitat., chest discomf., MI &   ros., salt & vol.deplet.pts., CHF, pt.at risk of symptom. hypotens. to
                                                              be monit.when ther.init./dos. adjustm., cerebrovasc./ischaem.heart
   20 mg dly.                   CVA second.to excess.hypotens.in high risk pts., tachycard., orthos-
   HF/asymptomat.L.ventric.dysfunct: Init. 2,5 mg incr.grad.to   tat.hypotens., vasculit., ren. fail./dysfunct., interstit.nephrit., diapho-  dis., maj. surg./ dur.anaesthes., diab.mellit., anaphylact. reacts.dur.
                                                              hymenoptera desens.treatm.& dur. haemodialys. proced.with high
   usual maint.dos.of 20 mg as sngl.dos./ 2 div.dos.as tol.titr.over a   res., uraem., oligur./anur., skin reacts.incl.sev.skin disords./ erythema
   period of 2-4 wks.           multiforme/tox. epiderm. necrolys./ Stev.John.syndr., photosens.,   flux membr./low-dens. lipoprot apheres.with dextr.sulf.absorpt., non-
                                                              product./persist.cough, autoimmun.dis.esp. syst. SLE/ scleroderma,
   Contraindications: Aort.stenos.& hypertroph. cardiomyopathy, an-  alopec., bld.disords., xanthops., blurr.vis., gout, electrol. imbal.incl.
   gioneurot.oed.hist.relat.to prev. ACE inhibit.treatm., porphyr., pregn.&   hyponatraem., sialoadenit., impot, sympt. compl.incl.arthral./myalg./  bil.ren.artery stenos./arter. stenos.to sngl.kidn./ren.transplant., ther.
   lactat., paed. use not studied, concom.Ca antagon.not recomm.  arthrit., hyperkalaem., liv.enzyme elev., hypercalcaem., gluc. tol.im-  not to be init.in ac. MI if pt.at risk of furth.ser. haemodynam. deterio-
   Side effects: CNS effs., asthen., hypotens., syncope, GI disturbs.,   pairm., incr.triglycer./cholestr.lev., SLE exacerbat./activat.  rat. aft.treatm.with vasodilat., collagen vasc. dis./immunosuppress.
   musc.cramps, rash, cough, ren. dysfunct., hypersens., angioneurot.  Special precautions: Discont.& switch.to diff. antihypertens.if   ther./concom. allopurinol/ procainamide esp.in pres.of imp.ren. funct.
   oed., CV disords. incl.MI/CVA poss.second.to excess. hypotens. in   woman becom.pregn./if pregn. plann., poss.foet./neonat.morbit/  in which case per.white cell count monit.& signs of infect.report., dis-
                                        nd
                                           rd
   high risk pts., palpitat., rhythm disturbs., ang.pect., nerv./resp./skin   mortalit.if giv. dur.2  & 3  trimest., pass.through placenta, poss.pre-  cont.ther.& init.emerg. treatm.in case of poss.fatal laryng./tong.oed.,
   disords., impot., flush., taste alterat., tinnit., glossit., blurr. vis., fev.,   matur./low birth mass, monit.infts.of mothers who recd.ther., poss.  no re-challenge with any ACE-inhibit., pts.with angioed. hist.unrelat.
   serosit., vasculit., myalg., arthralg., arthrit., bld.disords., photosens.,   foet./neonat.jaund., routine diuret.use in healthy pregn.women not   to ACE-inhib.ther.at incr.risk, poss. discont.ther.in pts.with hypotens.
   hyperkalaem.& hyponatraem.   recomm., thiazid.appears in breast milk, monit.ser. K if concom.K - +  with no evid. of pre-exist.ren vasc.dis.esp.if giv.concom. with diuret.,
                                                      +
                                           +
                                     +
   Special precautions: Secret.in breast milk, diuret. Ther., vol./salt   supplem./K -spar.diuret./K -contain. salts necess., poss.high Li-toxic   ther.not to be init.in MI pts.with evid. of ren.dysfunct.&/proteinur.,
   deplet.pts., monit.BP, ren. funct. & ser.K in HF, ischaem.heart dis./   risk, mod./ sev.ren.funct. impairm., vol.& salt deplet., if poss. discont.  withdr.ther.should ren. dysfunct.devel., elderly with decr.ren.funct.
   cerebrovasc. dis., hypotens., ren.impairm., surg./ anaesthes., de-  diuret.ther.2-3 days bef.init.treatm. otherw. admin.alone at init.dos.of   Interactions: Li-clear.poss.reduc.theref.lev.to be monit., poss.hy-
                                                                                  +
                                                                            +
                                                                      +
   sensitisat.with hymenoptera venom, poss. anaphylact.reacts.in pts.  5 mg., hypotens., electrol/fluid imbal., monit.electrol. when at risk,   perkalaem.with K -spar.diuret./K  supplem./ K cont.salt substit.,
   dialys.with high flux membr., concom.ganglion.block.agents/adren-  monit.treatm.init./dos.adjustm.in pts. with incr.orthost.hypotens.risk,   add.antihypertens. eff.with diurets./alcoh., poss.incr.bld.gluc.lower.
   erg. block. agents., diab.mellit., concom.K-supplem./K-spar. diuret.&   ischaem.heart/ cerebrovasc. dis., bilat./unilat.ren.artery stenos.in   eff./hypoglycaem risk with antidiab.meds., indomethcin dimin.act.,
   +
   K contain.salt substit.      pres. of sngl.kidn., poss.anaphylactoid reacts exper. dur.desensiti-  NSAIDs may furth.deterior. ren.funct.in compromis. pts., nitritoid
   Drug interactions: Other antihypertens./diuret. incr. eff., ß-adren-  sat.treatm./haemodialys. proced. using high-flux membran., hepat.  reacts.with inj. gold, furth.BP reduct.with TCA’s/antipsychot./ cert.
   erg.block.agents/methyldopa/Ca entry blockers potent.hypotens.  impairm. / progress.liv.dis., maj.surg./anaesth., poss.dos. adjustm.   anaesthet., reduc.antihypertens.eff.with sympathomimets., incr.an-
   eff., Li elimin. reduc.      of antidiab.agents incl.insul., do not re-challenge aft.angioed.react.,   gioed.risk with tiss. plasminog. activat.
                                sens.reacts.poss. with /-out allergy/bronch.asthma hist., angioed.
   LIRACEN, Aurobindo [P/S]     hist. unrelat.to ACE inhibit.may incr.angioed.risk when taking ACE-  LISORETIC, Pharma Dynamics
   Ramipril                     inhibits., high.incid.of angioed.in black pts., discont.if incr.bld.urea &   Lisinopril 10(20)mg, hydrochlorothiazide 12,5 mg.
   Indications: Mild to mod.hypertens., card.fail. follow. MI., reduc.  ser. creatin. occur with no appar.pre-exist.ren.dis., poss. underly. hy-  Indications: Mild to mod.hypertens.stabilis.on indiv. component.
   proteinur.& glomerul.filtrat.rate decline in diabet.nephropathy &   perparathyroid.in case of mark. hypercalcaem.  giv.in same proport.
   hyperten., reduc. risk. of.MI. stroke, or card.vasc.death & need for   Drug interactions: K -supplem./K -spar. diuret. /K -contain.salts   (S3) TABS, 37/7.1.3/0475, 0476
                                          +
                                               +
                                                      +
   revascularisat.proced.in pts with incr.CV risk, reduc. risk.of.MI/stroke,   esp.in ren. dysfunct. incr.ser.K , Li.clear.reduc., NSAID’s poss.decr.  704437-001: 10/12,5 mg, 30, R53,40
                                             +
   or card.vasc.death in. diab. pt.  antihypertens. diuret./ natriuret.effic., incr.responsiv.to tubocurar.,   704438-001: 20/12,5 mg, 30, R92,40
   (S3) CAPS. 44/7.1.3/1075, 1076  addit.eff.with other antihypertens. agents., alcoh./barbits.& narcot.  Dosage:  Usual dos: 1 tab once/day admin.at approx. same time dly.
   3000178-001: 5 mg, 30, R183,97  may potent. orthostat. hypotens., corticoster.& ACTH intens. electrol.  Max 2 tabs once dly.if respons.inadeq.aft.2-4 wks.
   3000179-001: 10 mg, 30, R195,47  deplet.& hypokalaem., decr.respons.to pressor amines.  Contraindications: Anur., hist.of angioed.with ACE-inhibit., heredit./
   Dosage: Hypertens: Init.2,5 mg dly in pts.not on diuret. Incr.to 5 mg   idiopath angioed., sulphonam. sens., pregn.& lactat., aortic.stenos./
   and max.10 mg dly at 1-2 wk. interv.depend.on respon.  LISO, (Unicorn) Pharma Dynamics [P/S]  hypertroph. cardiomyopathy.
   Post MI: Init.2,5 mg 2xdly x2 days 3-10 days aft.ac.MI. If heart fail   Lisinopril.  Side effects: GI disturbs., CNS/psych.effs., headache, dry mouth,
   manifests & pt. haemodynamic stable.incr.to 5 mg 2xdly if well tol. If   Indications: Mild to mod.hypertens.alone/ concom. other hyper-  dizzin., fev., vertigo, musc. cramps/spasm, weakn., hyperglycaem.,
   init. dos.of 2,5 mg not tol.init.with 1,25 mg 2xdly incr. to 2,5 mg 2xdly.  tens., adjunct in CHF with diurets. & digital.where appropr., within   glycosur., hepatit., jaund., pancreatit., dry persist.cough, resp. distress.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page138.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page134.html">134</a>&nbsp;&nbsp;&nbsp;<a href="page135.html">135</a>&nbsp;&nbsp;&nbsp;<a href="page136.html">136</a>&nbsp;&nbsp;&nbsp;<a href="page137.html">137</a>&nbsp;&nbsp;&nbsp;<a href="page138.html">138</a>&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>
             </td>
             <td width="35%"><a href="page140.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page140.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
